Kalbe Farma Tbk PT

Common Name

Kalbe Farma

Country

Indonesia

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

12,903

Ticker

KLBF

Exchange

INDONESIA STOCK EXCHANGE

Website

www.kalbe.co.id

Description

Kalbe Farma Tbk. PT is a prominent pharmaceutical corporation in Indonesia known for its extensive range of healthcare products and services. As a leader in the pharmaceutical industry, its primary fu... Show more

Income Statement Balance Sheet Group Entities

Kalbe Farma's Financial Statements Preview

Below are the financial statements of Kalbe Farma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in billions of IDR	2024 as of 2024-12-31	2023 as of 2023-12-31
Assets	—	—
Current assets	—	—
Cash and cash equivalents	4,723.29^a	3,232.42^a
Trade receivables	—	—
Third parties, net	4,811.9^a	4,600.11^a
Related parties	52.65^a	51.86^a
Other receivables	—	—
Third parties	142.75^a	155.02^a
Related parties	5.86^a	13.15^a
Other current financial assets	143.14^a	165.5^a
Inventories, net	6,501.63^a	6,791.98^a
Prepaid tax	454^a	465.51^a
Prepaid expenses	45.25^a	37.37^a
Other current assets	307.19^a	404.81^a
Total current assets	17,187.67^a	15,917.72^a
Non-current assets	—	—
Other non-current financial assets	311^a	321.06^a
Investment in associates	206.61^a	129.74^a
Deferred tax assets, net	120.35^a	136.1^a
Claims for tax refund	406.19^a	128.67^a
Fixed assets, net	8,269.38^a	7,978.03^a
Intangible assets, net	2,315.73^a	1,778.03^a
Right-of-use assets, net	103.66^a	89.01^a
Other non-current assets	509.13^a	579.2^a
Total non-current assets	12,242.06^a	11,139.84^a
Total assets	29,429.73^a	27,057.57^a
Liabilities	—	—
Current liabilities	—	—
Short-term bank loans	269.1^a	120.8^a
Trade payables	—	—
Third parties	1,810.74^a	1,584.84^a
Related parties	81.42^a	105.88^a
Other payables	—	—
Third parties	931.97^a	547.97^a
Related parties	0.3^a	0.26^a
Accrued expenses	600.22^a	369.12^a
Short-term employee benefits liabilities	172.29^a	109.43^a
Taxes payable	248.82^a	225.2^a
Current maturities of	—	—
Bank loans	53.01^a	157.49^a
Lease liabilities	17.07^a	21.47^a
Finance payables	0.81^a	0.72^a
Total current liabilities	4,185.75^a	3,243.17^a
Non-current liabilities	—	—
Long-term debts, net of current maturities	—	—
Bank loans	65.46^a	298.34^a
Lease liabilities	25.06^a	20.44^a
Finance payables	1.56^a	2.37^a
Convertible note	129.53^a	0^a
Deferred tax liabilities, net	63.08^a	35.79^a
Long-term employee benefits liability	368.36^a	336.94^a
Other long-term payable	—	—
Related party	0.5^a	0.5^a
Total non-current liabilities	653.54^a	694.38^a
Total liabilities	4,839.29^a	3,937.55^a
Equity	—	—
Equity attributable to owners of the parent company	—	—
Share capital - Rp10 par value per share	468.75^a	468.75^a
Additional paid-in capital, net	-29.06^a	-34.12^a
Differences arising from transactions with non-controlling interests	373.94^a	377.21^a
Retained earnings	—	—
Appropriated	371.69^a	344.02^a
Unappropriated	22,941.79^a	21,162.75^a
Treasury stock - 923,657,900 shares as of december 31, 2024 and 619,480,700 shares as of december 31, 2023	-1,462.39^a	-1,003.97^a
Other comprehensive income	—	—
Differences arising from foreign currency translation	81.66^a	40.08^a
Unrealized gain on available-for-sale financial assets, net	97.39^a	98.34^a
Actuarial loss on long-term employee benefits liability, net	-54.89^a	-34.2^a
Sub-total	22,788.88^a	21,418.86^a
Non-controlling interests	1,801.55^a	1,701.17^a
Total equity	24,590.43^a	23,120.02^a
Total liabilities and equity	29,429.73^a	27,057.57^a

Download Data

Verified Sources Behind Kalbe Farma’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Kalbe Farma’s data sources below and access millions more through our Disclosure Search.

a. Kalbe Farma's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Kalbe Farma Tbk PT

Kalbe Farma's Financial Statements Preview

Verified Sources Behind Kalbe Farma’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Organon & Co

Kyowa Kirin Co Ltd

Virbac SA

Roche Holding AG

CSPC Pharmaceutical Group Ltd

Bayer AG